clinical development plan
Recently Published Documents


TOTAL DOCUMENTS

44
(FIVE YEARS 0)

H-INDEX

6
(FIVE YEARS 0)

2016 ◽  
Vol 18 (2) ◽  
pp. 142-144 ◽  
Author(s):  
Andre Terzic ◽  
Atta Behfar ◽  
Gerasimos Filippatos

2014 ◽  
Vol 18 (05) ◽  
pp. 18-23

China Biologic receives GMP certification at its Guizhou Taibang facility. Hua Medicine's novel glucokinase activator reports positive Phase 1a data for diabetes and initiates Phase 1b trials. QIAGEN launches QuantiFERON-TB gold in-tube in China to aid tuberculosis control. AirWare Labs expands manufacturing and sales into China. Global Partners SillaJen, Transgene and Lee's Pharmaceutical confirm clinical development plan for Pexa-Vec. Gyros and Tekon Biotech sign distribution agreement. AstraZeneca and Shenzhen University Health Science Center to collaborate on chronic kidney disease. Bayer Healthcare to significantly increase production capacity in China.


Therapies ◽  
2012 ◽  
Vol 67 (4) ◽  
pp. 349-357
Author(s):  
Laurent Becquemont ◽  
Régis Bordet ◽  
Dominic Cellier ◽  
Marc Bardou ◽  
Philippe Beaune ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document